中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [6]
合肥物质科学研究院 [1]
采集方式
OAI收割 [7]
内容类型
期刊论文 [7]
发表日期
2023 [1]
2022 [1]
2019 [2]
2018 [1]
2017 [2]
学科主题
筛选
浏览/检索结果:
共7条,第1-7条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 259, 页码: 19
作者:
Wang, Pingyuan
;
Zhu, Wen-Ting
;
Wang, Yajing
;
Song, Shan-Shan
;
Xi, Yong
  |  
收藏
  |  
浏览/下载:71/0
  |  
提交时间:2023/10/17
PARP1 inhibitor
Synthetic lethality
Drug resistance
Anticancer
Structure -activity relationship
Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2022
作者:
Cao, Guo-Zhen
;
Ma, Li-Ying
;
Zhang, Zong-Hui
;
Wang, Xiao-Lin
;
Hua, Jing-Han
  |  
收藏
  |  
浏览/下载:49/0
  |  
提交时间:2022/12/22
small-cell lung cancer
H3
3
PARP1
PARP inhibitor
darinaparsin
combination treatment
USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells
期刊论文
OAI收割
CANCER MEDICINE, 2019, 卷号: 8, 期号: 15, 页码: 6730-6740
作者:
Lu, Qin
;
Zhang, Fang-Lin
;
Lu, Da-Yun
;
Shao, Zhi-Ming
;
Li, Da-Qiang
  |  
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2020/07/01
BRCA1
breast cancer
deubiquitinase
PARP inhibitor
USP9X
Increased PARP1-DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1-DNA trapping is correlated with PARP1 inhibitor's cytotoxicity
期刊论文
OAI收割
INTERNATIONAL JOURNAL OF CANCER, 2019, 卷号: 145, 期号: 3, 页码: 714-727
作者:
Chen, Hua-Dong
;
Chen, Chuan-Huizi
;
Wang, Yu-Ting
;
Guo, Ne
;
Tian, Yu-Nan
  |  
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2024/03/21
PARP1 inhibitor
PARP1-DNA binding
PARP1-DNA trapping
poly(ADP-ribose) polymerase activity
cytotoxicity
Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious Poly(ADP-ribose)polymerase (PARP) inhibitors
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 145, 页码: 389-403
作者:
Chen, Xuxing
;
Huan, Xiajuan
;
Liu, Qiufeng
;
Wang, Yuqin
;
He, Qian
  |  
收藏
  |  
浏览/下载:36/0
  |  
提交时间:2019/01/08
PARP1/2 inhibitor
Benzimidazole
4,5,6,7-Tetrahydrothienopyridine
Co-crystal structure
Isothermal Titration Calorimetry
Discovery of potent 2,4-difluoro-linker poly(ADP-ribose) polymerase 1 inhibitors with enhanced water solubility and in vivo anticancer efficacy
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2017, 卷号: 38, 期号: 11, 页码: 1521-1532
作者:
Chen, Wen-hua
;
Song, Shan-shan
;
Qi, Ming-hui
;
Huan, Xia-juan
;
Wang, Ying-qing
  |  
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2019/01/08
PARP-1 inhibitor
olaparib
breast cancer
BRCA-deficient tumors
discoveryofpotent24difluorolinkerpolyadpribosepolymerase1inhibitorswithenhancedwatersolubilityandinvivoanticancerefficacy
期刊论文
OAI收割
actapharmacologicasinica, 2017, 卷号: 38, 期号: 11, 页码: 1521
作者:
Chen Wenhua
;
Song Shanshan
;
Ql Minghui
;
Huan Xiajuan
;
Wang Yingqing
  |  
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2020/07/01
PARP INHIBITORS
MEDICINAL CHEMISTRY
DRUG DISCOVERY
CANCER
THERAPY
DESIGN
FLUORINE
SUCCESS
PREDICT
METRICS
PARP-1 inhibitor
olaparib
breast cancer
BRCA-deficient tumors